Abbott supported its CE mark approval with data from its FOCALFLEX CE mark study. The global clinical trial, conducted across ...
Interruption or Discontinuation After One Month Following Implant Procedure Posed ‘Low and No Increased Risk’ of Stent Thrombosis at One Year in Clinical Studies MINNEAPOLIS –– Of relevance to the ...
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, announced today the submission of a design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results